Uncategorized Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reaffirmed at HC Wainwright otakuyassine3@gmail.com Dec 23, 2024 Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by analysts...
Uncategorized Texas Roadhouse (NASDAQ:TXRH) Given Outperform Rating at Wedbush otakuyassine3@gmail.com Dec 20, 2024 Wedbush reiterated their outperform rating on shares of Texas Roadhouse (NASDAQ:TXRH – Free Report) in...
Uncategorized Tripadvisor (NASDAQ:TRIP) Receives “Neutral” Rating from Wedbush otakuyassine3@gmail.com Dec 20, 2024 Wedbush reissued their neutral rating on shares of Tripadvisor (NASDAQ:TRIP – Free Report) in a...
Uncategorized Rivian Automotive (NASDAQ:RIVN) Receives “Neutral” Rating from Robert W. Baird otakuyassine3@gmail.com Dec 19, 2024 Robert W. Baird restated their neutral rating on shares of Rivian Automotive (NASDAQ:RIVN – Free...
Uncategorized Wedbush Reiterates “Outperform” Rating for IDEAYA Biosciences (NASDAQ:IDYA) otakuyassine3@gmail.com Dec 17, 2024 IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “outperform” rating restated by equities...